RSLS - ReShape Lifesciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
-76,813
-81,152
-33,818
-23,361
Depreciation & amortization
1,415
441
925
140
Deferred income taxes
-910
-3,448
-2,315
-
Stock based compensation
2,277
3,098
4,437
2,331
Change in working capital
-3,353
857
1,448
1,891
Accounts receivable
-
-508
28
-106
Inventory
138
1,978
68
-103
Accounts Payable
-
317
-223
1,140
Other working capital
-20,012
-27,540
-24,725
-20,670
Other non-cash items
-
14
4,721
-3,513
Net cash provided by operating activites
-19,969
-27,490
-24,588
-20,656
Cash flows from investing activities
Investments in property, plant and equipment
-
-50
-137
-14
Acquisitions, net
-
-10,279
-6,231
-
Purchases of investments
-
-
-
-
Sales/Maturities of investments
-
-
-
-
Other investing activites
-
-
-
0
Net cash used for investing activites
-10,321
-10,328
-6,368
-14
Cash flows from financing activities
Debt repayment
-
-
0
-447
Common stock issued
-
-
6,468
-
Common stock repurchased
0
-500
-
-
Dividends Paid
-
-
-
-
Other financing activites
37,493
33,190
-4,525
-755
Net cash used privided by (used for) financing activities
37,543
33,203
37,808
16,053
Net change in cash
7,244
-4,615
6,852
-4,616
Cash at beginning of period
473
10,163
3,311
7,927
Cash at end of period
7,726
5,548
10,163
3,311
Free Cash Flow
Operating Cash Flow
-19,969
-27,490
-24,588
-20,656
Capital Expenditure
-
-50
-137
-14
Free Cash Flow
-20,012
-27,540
-24,725
-20,670